| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |